Adult ADHD: Recognition, Assessment and What Happens Next

This article walks through how adult ADHD is recognised and assessed in the UK in 2026. It covers the NICE pathway, the three routes to assessment, what a good assessment actually involves, and what the first weeks and months after diagnosis look like. It is written for adults who suspect they may have ADHD, and for partners or family members trying to make sense of the process.

Recognising the pattern

Adult ADHD is well documented in the research and increasingly well recognised clinically ^{[1, 2]}. The most common reasons adults reach the point of considering assessment are:

• A child or partner has been diagnosed and the picture sounds familiar
• A new job, parenthood, perimenopause or a stretch of burnout has tipped previously manageable workarounds into something that no longer works
• Treatment for anxiety or depression has produced a more limited response than expected and the underlying ADHD has become visible
• A long-running pattern of underperformance relative to ability has reached the point of needing an explanation

None of these are diagnostic on their own, but they are the patterns clinicians see most often at adult ADHD assessment.

DSM-5-TR criteria require persistent inattention, hyperactivity or impulsivity, present from before age twelve, in at least two settings, causing meaningful difficulty in daily life ^[3]. The adult symptom threshold is five symptoms in either cluster, lower than the six required in children, in recognition of how the presentation typically softens with age ^[3].

The three routes to assessment in the UK

NICE NG87 is the UK reference standard ^[1]. Assessment must be carried out by a clinician with training and experience in ADHD. Three main routes exist for adults in England.

NHS via GP referral

The default route. A GP referral goes to a local NHS adult ADHD service. Waiting times vary widely by region and frequently run into years. This is no fault of any individual clinician or service; it reflects a sustained mismatch between demand and capacity that has not been resolved.

Right to Choose in England

A legal entitlement under the NHS Constitution that allows patients in England to request referral to any provider that holds an NHS contract for ADHD assessment, often with shorter waiting times. The GP completes a referral to the chosen provider; assessment, diagnosis and any prescribing remain NHS-funded. How Right to Choose works in practice covers the practical detail. Right to Choose does not apply in the same form in Scotland, Wales or Northern Ireland.

Private assessment

Self-funded with a CQC-registered provider. Faster, paid out of pocket, with the option of subsequent shared care depending on local ICB acceptance. NeuroFX offers a private adult ADHD assessment along these lines, and a dedicated private adult ADHD assessment for women that explicitly covers masking, the menstrual cycle and perimenopause. A detailed picture of what private adult ADHD assessment actually looks like in the UK is in the linked piece.

What a good adult ADHD assessment covers

NICE NG87 sets out what an assessment must include ^[1]:

• A full clinical interview covering current symptoms, developmental history, and impact across multiple settings
• Evidence of childhood onset, ideally with a school report, parent or sibling informant where possible
• A review of mental and physical health for co-occurring and differential diagnoses
• Use of a structured tool such as the DIVA-5 to support, but not replace, the clinical interview
• Discussion of treatment options if ADHD is confirmed

The assessment is typically two to three hours, sometimes split across two sessions. A good clinician spends as much time on history as on symptoms; the lifelong pattern is the diagnostic anchor.

Common structured tools used in UK adult assessment include:

• DIVA-5 (Diagnostic Interview for ADHD in adults, fifth edition). Semi-structured interview covering DSM-5 criteria with concrete examples for adulthood and childhood. The most widely used adult ADHD interview in NHS and private practice ^[4].
• ASRS (Adult ADHD Self-Report Scale). A six- or eighteen-item self-report screen developed with the World Health Organization. Used for screening, not diagnosis.
• BAARS-IV (Barkley Adult ADHD Rating Scale-IV). Self-report and informant versions. Useful for triangulating with the clinical interview.
• Conners' Adult ADHD Rating Scales. Older but still in use in some services.
• QbCheck or similar objective attention tests. Add information about attention, impulsivity and motor activity in a controlled task. Useful in some cases; not diagnostic on their own.

No single tool confirms or rules out ADHD. The diagnosis is clinical, supported by the tools and the history.

Differential diagnosis

A thorough assessment considers what else could explain the picture, and what may be co-occurring ^{[1, 5]}:

• Anxiety and depression are highly co-occurring with ADHD in adults. They can also produce attention and concentration problems on their own.
• Sleep disorders, particularly obstructive sleep apnoea and insomnia, can mimic or worsen ADHD symptoms.
• Trauma, including complex PTSD, can produce attention difficulties and emotional dysregulation.
• Autism is highly co-occurring; combined assessment is increasingly common.
• Thyroid disease, iron deficiency and certain medications can produce attention symptoms.
• Substance use, including cannabis and stimulants, can affect attention.

A good assessment does not dismiss the question of ADHD because anxiety is present; it asks whether both fit, and which came first.

After the assessment: the report

NICE NG87 recommends a clear written report covering the diagnostic conclusion, the evidence supporting it, any co-occurring conditions identified, and the recommended next steps ^[1]. The report typically arrives within days to a few weeks of the final session, depending on the provider.

If ADHD is confirmed, the report will usually include:

• A formal diagnosis under DSM-5-TR or ICD-11 criteria
• A description of the presentation (inattentive, hyperactive-impulsive, or combined)
• Identified co-occurring conditions
• Treatment recommendations (psychoeducation, medication where appropriate, environmental adjustments, psychological support)
• Information about access to medication and shared care

If ADHD is not confirmed, the report explains what the difficulties may reflect and what further investigation or support might help.

What happens next: the first months

For most adults whose diagnosis is confirmed, the period after assessment involves three things in parallel.

Psychoeducation

Understanding the condition is itself part of treatment. Many adults find that reading, talking with other adults with ADHD, and reframing their own history takes weeks or months of active work. This is normal and useful.

Medication, where indicated

NICE NG87 recommends medication as a first-line option for most adults with ADHD whose symptoms cause significant impairment ^[1]. Stimulants (methylphenidate and lisdexamfetamine in the UK) are usually tried first; non-stimulants (atomoxetine, guanfacine) are alternatives where stimulants are unsuitable. Titration takes around three months for most people. The practical detail of ADHD medication and titration is covered in its own article. Specific doses are not addressed in patient-facing material; those are prescribing decisions.

Practical adjustments

Workplace reasonable adjustments under the Equality Act 2010, environmental changes at home, and structural changes to how time, money and admin are managed. The combination of medication and practical adjustments is what most reliably produces lasting change ^[2].

A note on shared care

If you go privately for assessment and start medication, ongoing prescribing can sometimes be transferred to your NHS GP under a shared care agreement. Whether this happens depends on:

• The diagnosing clinician's report meeting the GP's and ICB's expectations
• The local ICB accepting shared care for ADHD medication initiated privately
• A period of stability on a specific medication and dose (often three months or more)

Shared care is variable across the UK. Some ICBs accept it readily; others do not. NeuroFX will support a shared care request where the patient is suitable and offer continued private prescribing where shared care is declined.

What this means in practice

• If the pattern fits and has been there since childhood, that question is worth taking seriously regardless of which route you take to assessment.
• Bring evidence. Old school reports, parental memories, photos from childhood, an honest description of how you function across the working week. All of this helps a clinician see the lifelong pattern.
• Do not let a previous diagnosis of anxiety or depression settle the matter. Co-occurring mood symptoms in adults with ADHD are common, not exclusionary.
• Expect the diagnosis to reframe parts of your past as well as inform what happens next. That is a normal experience.
• The combination of medication, understanding and practical adjustments tends to outperform any single one of these alone.

When to speak to a professional

Speak to your GP if the pattern has been persistent across more than one area of life and dates back to childhood. NHS routes start there; Right to Choose in England is the same first conversation. NeuroFX offers private adult ADHD assessment from our Bedford clinic where waiting is a barrier. Seek same-day help via 111 (or 999 in an emergency) for any mental health crisis, including thoughts of self-harm.

Sources

1. NICE. Attention deficit hyperactivity disorder: diagnosis and management. NG87. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng87
2. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews. 2021;128:789-818.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022.
4. Kooij JJS, Bijlenga D, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European Psychiatry. 2019;56:14-34.
5. Asherson P, Buitelaar J, Faraone SV, Rohde LA. Adult attention-deficit hyperactivity disorder: key conceptual issues. Lancet Psychiatry. 2016;3(6):568-578.
6. NHS England. Your choices in the NHS. https://www.england.nhs.uk/contact-us/yhc/your-choices-in-the-nhs/